CEO of Fibrogen Inc (30-Year Financial, Insider Trades) Thomas B Neff (insider trades) sold 39,636 shares of FGEN on 07/25/2019 at an average price of $46.74 a share. The total sale was $1.9 million.
FibroGen Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of novel therapeutics to treat serious unmet medical needs. FibroGen Inc has a market cap of $4.14 billion; its shares were traded at around $48.04 with and P/S ratio of 19.84. GuruFocus has detected 5 severe warning signs with FibroGen Inc. .
CEO Recent Trades:
- CEO Thomas B Neff sold 39,636 shares of FGEN stock on 07/25/2019 at the average price of $46.74. The price of the stock has increased by 2.78% since.
- CEO Thomas B Neff sold 39,636 shares of FGEN stock on 07/11/2019 at the average price of $44.97. The price of the stock has increased by 6.83% since.
Directors and Officers Recent Trades:
- SVP, China Operations Christine Chung sold 11,250 shares of FGEN stock on 07/11/2019 at the average price of $44.97. The price of the stock has increased by 6.83% since.
- Director Kalevi Kurkijarvi sold 6,000 shares of FGEN stock on 07/08/2019 at the average price of $42.6. The price of the stock has increased by 12.77% since.
- SVP, Clinical Dev, Drug Safety Elias Kouchakji sold 2,873 shares of FGEN stock on 06/28/2019 at the average price of $45. The price of the stock has increased by 6.76% since.
For the complete insider trading history of FGEN, click here
.
